However, elevated levels of Mcl-1 have been reported for a number of solid tumors and B-cell chronic lymphocytic leukemia (B-CLL) as well as and AML and acute lymphoid leukemia (ALL) upon relapse [13-16]. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.